logo

CCEL

Cryo-Cell·AMEX
--
--(--)
--
--(--)
9.91 / 10
Outperform

CryoCell International's fundamentals are rated Outperform, reflecting an excellent status (9.9/10). Key bullish drivers include strong cash flow from operating activities per share and a positive Cash-MV difference. However, challenges persist in net income-to-revenue and earnings-per-share growth, indicating some profitability headwinds. Overall, the company's balance-sheet strength and cash generation capabilities support a superior fundamental stance, but investors should monitor earnings trends for signs of improvement.

Fundamental(9.91)SentimentTechnical

Analysis Checks(3/10)

Revenue-MV
Value-0.08
Score0/3
Weight-122.58%
1M Return-2.93%
Net cash flow from operating activities per share (YoY growth rate %)
Value9.02
Score3/3
Weight283.00%
1M Return5.16%
Net income-Revenue
Value-0.81
Score0/3
Weight-9.82%
1M Return-0.21%
Basic earnings per share (YoY growth rate %)
Value-39.29
Score0/3
Weight-118.78%
1M Return-3.08%
Total profit (YoY growth rate %)
Value-37.07
Score0/3
Weight-172.77%
1M Return-4.70%
Net cash flow from operating activities (YoY growth rate %)
Value8.92
Score3/3
Weight289.55%
1M Return5.21%
Diluted earnings per share (YoY growth rate %)
Value-37.04
Score0/3
Weight-115.31%
1M Return-3.01%
Asset-MV
Value-0.50
Score1/3
Weight87.83%
1M Return1.95%
Net profit attributable to parent company shareholders (YoY growth rate %)
Value-38.68
Score0/3
Weight-140.32%
1M Return-3.80%
Cash-MV
Value0.20
Score2/3
Weight119.21%
1M Return2.59%
Is CCEL fundamentally strong?
  • CCEL scores 9.91/10 on fundamentals and holds a Discounted valuation at present. Backed by its 0.00% ROE, -1.49% net margin, -57.49 P/E ratio, -1.84 P/B ratio, and 94.34% earnings growth, these metrics solidify its Outperform investment rating.